Cancer Biology

Search results

• Mount Sinai Announces Landmark Gift from James S. and Merryl H. Tisch to Transform Cancer Care in New York

  Ramon Parsons,, Ajai Chari & Kenneth L. Davis

  23/08/21 → 25/08/21

  14 items of Media coverage

  Press/Media

• Mount Sinai Announces Landmark Gift from James S. and Merryl H. Tisch to Transform Cancer Care in New York.

  Ramon Parsons,, Ajai Chari & Kenneth L. Davis

  25/08/21

  1 item of Media coverage

  Press/Media

• Mount Sinai Announces Landmark Gift from James S. & Merryl H. Tisch to Transform Cancer Care in New York

  Ramon Parsons,, Ajai Chari & Kenneth L. Davis

  23/08/21

  1 item of Media coverage

  Press/Media

• Study could combat aggressive chemotherapy resistant TNBC

  Hanna Irie & E. Reddy

  4/08/21

  1 item of Media coverage

  Press/Media

• Mount Sinai Seeking Pharma Partner to Advance Promising AKT Degrader

  Ramon Parsons,

  30/07/21

  1 item of Media coverage

  Press/Media

• Researchers develop novel therapy that could be effective in many cancers

  Ramon Parsons, & Jian Jin

  23/07/21 → 26/07/21

  2 items of Media coverage

  Press/Media

• Mount Sinai Researchers Develop Novel Therapy That Could Be Effective in Many Cancers

  Ramon Parsons, & Jian Jin

  23/07/21 → 24/07/21

  12 items of Media coverage

  Press/Media

• Novel therapeutic agent could be effective for treating cancers with certain gene mutations

  Ramon Parsons, & Jian Jin

  24/07/21

  2 items of Media coverage

  Press/Media

• Mount Sinai Researchers Develop Novel Therapy That Could Be Effective in Many Cancers.

  Ramon Parsons, & Jian Jin

  23/07/21

  1 item of Media coverage

  Press/Media

• Science is wiping out cancer

  Ramon Parsons, & Jian Jin

  23/07/21

  1 item of Media coverage

  Press/Media

• Mount Sinai researchers develop engineered molecule that may disrupt enzyme in many cancers

  Ramon Parsons,

  23/07/21

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Develop Novel Therapy That Could Be Effective in Many Cancers; Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, accordin

  Ramon Parsons, & Jian Jin

  23/07/21

  4 items of Media coverage

  Press/Media

• Internationally Renowned Breast Cancer and HIV-Associated Malignancy Expert to Join Mount Sinai

  Ramon Parsons, & Joseph Sparano

  8/06/21 → 28/06/21

  15 items of Media coverage

  Press/Media

• Internationally Renowned Breast Cancer and HIV-Associated Malignancy...

  Ramon Parsons, & Joseph Sparano

  8/06/21

  3 items of Media coverage

  Press/Media

• Internationally Renowned Breast Cancer and HIV-Associated...

  Ramon Parsons, & Joseph Sparano

  8/06/21

  1 item of Media coverage

  Press/Media

• Internationally Renowned Breast Cancer and HIV-Associated Malignancy Expert to Join Mount Sinai.

  Ramon Parsons, & Joseph Sparano

  8/06/21

  1 item of Media coverage

  Press/Media

• HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness

  Vladimir Roudko & Ernesto Guccione

  2/06/21

  1 item of Media coverage

  Press/Media

• Anti-inflammatory drug protects against lethal inflammation from COVID-19 in animal models

  Robert Sebra & Ernesto Guccione

  30/03/21

  1 item of Media coverage

  Press/Media

• Anti-inflammatory therapies have potential to prevent heart disease in the elderly

  Eirini Papapetrou,

  18/03/21

  1 item of Media coverage

  Press/Media

• Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement

  Mihaela Skobe,

  4/03/21

  4 items of Media coverage

  Press/Media

• Vaxalto Biotherapeutics And Mount Sinai Enter Into Exclusive License Agreement For The Development And Commercialization Of Novel Immunotherapeutic Oncolytic Viruses For Treatment Of Cancer

  Mihaela Skobe,

  3/03/21 → 4/03/21

  16 items of Media coverage

  Press/Media

• Using CRISPR To Create Model Of AML Progression

  Eirini Papapetrou,

  14/02/21

  1 item of Media coverage

  Press/Media

• Sinai team builds first model acute myeloid leukemia progression using CRISPR

  Eirini Papapetrou,

  10/02/21

  2 items of Media coverage

  Press/Media

• Mount Sinai-Led Team Builds First Model of Progression of Acute Myeloid Leukemia Using CRISPR

  Eirini Papapetrou,

  10/02/21

  1 item of Media coverage

  Press/Media

• Mount Sinai-Led Team Builds First Model of the Progression of Acute Myeloid Leukemia using CRISPR

  Eirini Papapetrou,

  10/02/21

  2 items of Media coverage

  Press/Media